As of May 2022 uniQure has a market cap of $0.64 Billion. This makes uniQure the world's 4766th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $0.64 B | -33.23% |
2021 | $0.95 B | -40.38% |
2020 | $1.60 B | -48.68% |
2019 | $3.13 B | 190.99% |
2018 | $1.07 B | 78.41% |
2017 | $0.60 B | 328.64% |
2016 | $0.14 B | -65.02% |
2015 | $0.40 B | 50.23% |
2014 | $0.26 B |
On May 21st, 2022 the market cap of uniQure was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Amgen AMGN | $132.21 B | 20,558.35% | ๐บ๐ธ USA |
![]() Sanofi SNY | $135.85 B | 21,127.05% | ๐ซ๐ท France |
![]() Sangamo Therapeutics
SGMO | $0.60 B | -5.11% | ๐บ๐ธ USA |
![]() bluebird bio
BLUE | $0.23 B | -63.49% | ๐บ๐ธ USA |
![]() BioMarin Pharmaceutical BMRN | $14.74 B | 2,204.33% | ๐บ๐ธ USA |
![]() Avidity Biosciences RNA | $0.64 B | 0.69% | ๐บ๐ธ USA |